(RTTNews) - Novavax, Inc. (NVAX) announced Tuesday progress on its collaboration and license agreement (CLA) with Sanofi SA (SNY) regarding Novavax's Matrix-M adjuvant. The companies have amended ...
Add Yahoo as a preferred source to see more of our stories on Google. This assessment and productivity tool is named for former president Dwight Eisenhower, who once quoted Dr. J. Roscoe Miller’s ...
Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...
Q: When doing posterior composites, what are you using for your class II matrix? A: There are a lot of matrix systems available that all claim to create the perfect morphology and contact with ...
Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results